Thomas Hikaru Clark was a high school teacher with no plans for academia when he learned about the research being done at MIT’s Department of Brain and Cognitive Sciences.
David Orenstein | Picower Institute for Learning and Memory
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
MIT researchers uncover the structural properties and dynamics of deep classifiers, offering novel explanations for optimization, generalization, and approximation in deep networks.
